5-alpha-dihydroprogesterone has been researched along with Carcinogenesis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elizalde, PV; Mercogliano, MF; Rivas, MA; Schillaci, R; Wiebe, JP | 1 |
1 other study(ies) available for 5-alpha-dihydroprogesterone and Carcinogenesis
| Article | Year |
|---|---|
Progesterone-induced stimulation of mammary tumorigenesis is due to the progesterone metabolite, 5α-dihydroprogesterone (5αP) and can be suppressed by the 5α-reductase inhibitor, finasteride.
Topics: 5-alpha Reductase Inhibitors; 5-alpha-Dihydroprogesterone; Animals; Breast; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cholestenone 5 alpha-Reductase; Female; Finasteride; Humans; Mice; Mice, Inbred BALB C; Progesterone | 2015 |